Iterum Therapeutics plc (ITRMF) Gross Margin (2025)
Iterum Therapeutics (ITRMF) posted Gross Margin of 94.87% for Q3 2025.
Analysis
Iterum Therapeutics plc (ITRMF) Gross Margin (2025) Analysis & Trends
Iterum Therapeutics has reported Gross Margin for 1 years, with the latest figure at 94.87% in Q3 2025.
Peer Set